HS 3004 · 30

Find verified buyers for
Pharmaceutical formulations

HS 3004 covers medicaments in measured doses for therapeutic or prophylactic use. India is the world's third-largest pharma exporter by volume and supplies over 20% of global generics. Hyderabad-Telangana and Gujarat lead formulation exports. India exported $17.6 billion of Pharmaceutical formulations (HS 3004) globally in FY24-25 (DGFT data). The key export markets are USA, UK, UAE, GERMANY, SAUDI-ARABIA. Select a destination market below to see the full tariff, NTM, and buyer-discovery breakdown.

India exports $17.6 billion/yr for HS 3004·5 key destination markets·100% BANT-verified buyers

Top Indian manufacturing clusters for HS 3004

Ahmedabad
Gujarat
India's denim capital; major pharma API and bulk-chemicals exporter
Mumbai
Maharashtra
India's financial + pharma capital; major textile and gem-jewellery export hub
Vadodara
Gujarat
Major pharma API and specialty-chemicals exporter

Indicative cluster mapping. Data current as of FY24-25 unless otherwise noted.

Common certifications for HS 3004 exports

USFDAEU-GMPWHO-GMPMHRA (UK)TGA (Australia)

Certification requirements vary by destination market and sub-heading. Verify current requirements with DGFT, relevant EPCs, and the destination country's import authority before shipment.

Want a full market analysis for HS 3004?

diipl's free Custom Product Report covers tariff corridors, top importers, CAGR, price benchmarks, and a recommended entry strategy — produced within 24 business hours.